Thread by @brianreid

A quick thread on pharma companies and #COVID19. These are tough times, and it's worth the reminder that *all* biopharma companies have patient assistance programs that more generous and easier to access than most people think.

1/

(In the interest of disclosure, some of the names I mention may be #clients, but I'm not tweeting in support of any one company, announcement or program. I just want to make sure there is as much awareness as possible.)

2/

Here are some companies that are specifically highlighting efforts they're making given the COVID-19 related disruption:

3/

BMS said today that it would expand its access program for provide immediate access for patients who have lost their employment and health insurance.

businesswire.com/news/home/2020…

4/

Eli Lilly said today that "in response to the crisis caused by COVID-19," they're rolling out a new program in which all commercially insured and uninsured patients can get Lilly insulin for a $35 co-pay.

investor.lilly.com/news-releases/…

5/

Pfizer also said it changed it patient assistance program "to accommodate the challenges eligible patients are facing."

businesswire.com/news/home/2020…

6/

AbbVie has a specific webpage titled: "If you are unable to pay for your medicine due to COVID-19 circumstances"

abbvie.com/patients/patie…

7/

I'm sure I'm missing others. Please flag 'em below.

As a general rule, the @PhRMA Medicine Assistance Tool -- a search engine for patient assistance -- is a great way to determine what resources might be available if you are in need.

mat.org

8/

And, finally a shout out to all of those biopharma companies who are also working overtime on the innovation end of things. I expect this chart will need to up updated, maybe tomorrow, when we hit 400 trials.

https://twitter.com/brianreid/status/1246845731836776448

9/

--30--